How safety and compliance companies support medical device manufacturers
What safety and compliance companies actually do
Safety and compliance companies help medical device manufacturers turn regulations, standards, test work and audit expectations into evidence that regulators, notified bodies and purchasers can review. In medical devices, this is more than checking a product against a generic list. A useful partner connects risk management, design controls, verification testing, cybersecurity, labeling, supplier controls, complaints and post-market obligations into one traceable compliance story.
The manufacturer still owns compliance. Outside firms provide technical capacity, independent testing, certification, audit readiness or regulatory interpretation. That distinction matters because recent U.S. and EU rules have made quality-system evidence and lifecycle surveillance more visible. The FDA’s Quality Management System Regulation took effect on February 2, 2026 and aligns 21 CFR Part 820 more closely with ISO 13485:2016. In the EU, the Medical Device Regulation has applied since May 26, 2021, with notified bodies assessing conformity for many device classes.
For readers tracking related regulatory developments, 51jobdoc maintains ongoing safety and compliance coverage across the medical device sector.
Why medical device companies use outside compliance partners
Manufacturers usually bring in outside compliance partners for one of four reasons: they need independent evidence, they lack a specialized skill, they face a deadline, or they are entering a market with unfamiliar rules. A startup may need help building an ISO 13485 quality management system before formal design transfer. A connected device company may need cybersecurity documentation and penetration testing. A manufacturer of powered equipment may need electrical safety and electromagnetic compatibility testing under the IEC 60601 series. A company entering Europe may need support preparing technical documentation for notified body review.
The value is not simply speed. Strong safety and compliance companies reduce rework by identifying which evidence is needed for the intended use, classification, technology and target jurisdiction. A poor match can create the opposite result. A general consultant may produce polished templates that do not fit the device’s risk profile. A test lab may apply a standard edition that is not the one expected by the target regulator or purchaser. A certification body may issue a certificate that is useful for one purpose but not sufficient for another.
The main types of safety and compliance companies
The phrase safety and compliance companies covers several different provider types. Treating them as interchangeable is a common purchasing mistake in medical device compliance.
| Provider type | Typical role | Evidence or output to expect | Key due diligence question |
|---|---|---|---|
| Testing and inspection laboratories | Product safety, EMC, biocompatibility, packaging, sterilization, software or cybersecurity testing | Protocols, test reports, deviation records and sometimes product certificates | Is the lab accredited or recognized for the exact standard, method and device category? |
| Certification bodies and notified bodies | ISO 13485 certification, MDR conformity assessment or other formal certification activity | Audit reports, certificates, nonconformity records and surveillance audit findings | Is the organization designated or accredited for the required regulation, scope and codes? |
| Regulatory consulting firms | Classification, market pathway strategy, submission preparation, technical file remediation and gap assessments | Regulatory strategy, checklists, submission sections, technical documentation reviews and response plans | Can the firm show relevant experience with the same device type and market pathway? |
| Quality system and audit specialists | QMS design, internal audits, supplier audits, CAPA remediation and MDSAP readiness | Procedures, training records, audit reports, CAPA plans and management review inputs | Will the work strengthen the operating system, not just create documents for an audit? |
| Software and cybersecurity specialists | Threat modeling, software lifecycle evidence, SBOM support, vulnerability testing and secure update planning | Security risk files, architecture reviews, test reports and vulnerability management procedures | Do they understand medical device risk management and premarket submission expectations? |
Regulatory changes that affect provider selection
In the United States, the QMSR is a major reason manufacturers are reassessing their compliance partners in 2026. The FDA’s final rule, published in the Federal Register on February 2, 2024, incorporated ISO 13485:2016 by reference into the revised Part 820 and changed the title from Quality System Regulation to Quality Management System Regulation. This does not mean an ISO 13485 certificate is the same thing as FDA clearance, approval or inspection readiness. It means the quality-system language is more closely aligned with the international standard, while FDA-specific obligations still remain.
In Europe, MDR conformity assessment places heavy emphasis on technical documentation, clinical evaluation, post-market surveillance, vigilance and the manufacturer’s ability to maintain evidence after market entry. Notified bodies have a formal role for many device classes, but the legal manufacturer remains responsible for the device and its compliance system. The European Commission also continues to manage the phased implementation of EUDAMED, so manufacturers should verify current database obligations instead of relying on old transition assumptions.
Internationally, the Medical Device Single Audit Program is another area where provider type matters. The FDA describes MDSAP as a program that allows a recognized auditing organization to conduct a single regulatory audit intended to satisfy requirements of participating authorities. As of the FDA’s current MDSAP information, full participating members include regulators from Australia, Brazil, Canada, Japan and the United States. MDSAP can reduce duplicated audit effort, but it is not a universal replacement for every market requirement.
How to evaluate a provider before signing a contract
A practical evaluation should start with the device, not the vendor brochure. Define the intended use, device class, technology, patient contact, software features, power source, sterile status, target countries and planned submission route. Then decide which parts of the compliance case require independent evidence and which parts must remain under internal ownership.
For testing providers, confirm the exact standard title, edition, national deviations and accreditation scope. IEC 60601-1, for example, addresses basic safety and essential performance for medical electrical equipment, but many devices also need collateral or particular standards. A pre-scan may be useful during design, while final accredited testing should be timed for a design that is stable enough to avoid unnecessary retesting.
For regulatory consultants, ask who will do the work, not only which company brand appears on the proposal. Medical device submissions and technical files are detail-heavy. The difference between a senior reviewer and a junior template editor can determine whether the output anticipates regulator questions or simply reorganizes existing documents.
For certification and audit partners, verify independence and scope. A company that helps build your QMS may not be appropriate to certify the same system if conflict-of-interest rules apply. For EU MDR, check notified body designation, device codes and capacity early, because the wrong assumption can affect launch planning.
A stage-by-stage way to use compliance partners
The best use of outside expertise changes by product stage. Early in development, the highest-value support is usually classification, intended-use refinement, standards mapping and risk-management planning. At this point, design choices are still flexible and risk controls can be built into the product rather than patched later. See also: clinical equipment.
During design and verification, safety and compliance companies can help translate standards into testable requirements. That may include EMC pre-compliance work, usability engineering, software documentation, biocompatibility planning, packaging validation or cybersecurity review. The goal is not to pass tests in isolation. It is to show that verification evidence traces back to hazards, requirements and acceptance criteria.
Before submission or certification review, outside specialists can pressure-test the evidence package. For a U.S. 510(k), FDA has required most 510(k) submissions to use eSTAR since October 1, 2023 unless exempted. For EU MDR, the review focus will be broader than product testing and typically includes clinical, risk, labeling and post-market evidence. After launch, outside partners may support complaint trending, vigilance decisions, supplier audits, periodic reports or CAPA remediation, but the manufacturer must keep decision-making authority and records under control.
What manufacturers should not outsource
Outside partners can supply knowledge and evidence, but they cannot become the manufacturer’s quality conscience. The legal manufacturer should retain ownership of risk acceptability, design decisions, labeling claims, release criteria, supplier qualification and post-market decisions. Delegating tasks is normal; delegating accountability is not.
Manufacturers should also avoid confusing administrative records with market authorization. FDA establishment registration and device listing are annual obligations for many establishments involved in production and distribution of devices intended for the U.S. market, but FDA states that registration or listing does not denote approval, clearance or authorization of the establishment or product. A compliance partner can help complete these steps, but marketing claims must still be tied to the correct regulatory status.
The same caution applies to certificates. An ISO 13485 certificate can support confidence in a quality management system, but it does not automatically prove that a particular device is cleared for sale in the United States or CE marked under MDR. A test report may show conformance to a method, but only within the tested configuration and acceptance criteria. Each document must be connected to the intended claim.
Checklist for choosing safety and compliance companies
- Define the device category, intended use, risk profile and target markets before requesting quotes.
- Ask for the provider’s exact scope, accreditation, recognition or designation, not only general experience.
- Confirm which standards, editions and guidance expectations will be used.
- Request sample deliverable structures, such as test report indexes or audit report formats, without asking for another client’s confidential data.
- Clarify who owns source documents, raw data, protocols, deviations and final reports.
- Check whether subcontractors will be used and whether their scope is equally appropriate.
- Build review time into the schedule for failed tests, nonconformities, CAPA work and regulator questions.
- Require plain-language explanations of limitations, assumptions and unresolved issues.
The strongest provider relationship is transparent. A good partner will tell a manufacturer when evidence is missing, when a claim is not supportable, and when a cheaper shortcut is likely to create downstream risk. That advice may be uncomfortable during development, but it is usually less costly than discovering the problem during a submission review, notified body audit or post-market investigation.
Frequently asked questions
Are safety and compliance companies the same as notified bodies?
No. A notified body is a specific type of organization designated to perform conformity assessment under EU rules for certain products and scopes. Many safety and compliance companies are consultants, laboratories or audit specialists. They may prepare evidence or perform testing, but they do not automatically have notified body authority.
Does ISO 13485 certification mean a device is approved by FDA?
No. ISO 13485 certification can be important quality-system evidence, and the FDA’s QMSR now aligns Part 820 more closely with ISO 13485:2016. However, FDA clearance, approval, authorization, registration, listing and inspection outcomes are separate concepts.
When should a medical device startup hire a compliance partner?
Early enough to influence design decisions. The best time is usually before design verification is locked, because classification, standards mapping, risk controls, usability, software architecture and labeling claims can affect both testing and submission strategy.
Can one company handle all compliance work?
Sometimes, but manufacturers should be careful. A large provider may offer consulting, testing and certification services, yet independence rules and scope limits still apply. It is often safer to use one lead advisor with specialized labs or certification bodies where independent evidence is required.
What is the biggest mistake when choosing a provider?
The biggest mistake is buying a recognizable name without verifying scope. In medical devices, the relevant question is not whether a company is well known; it is whether the team, accreditation, standard edition, regulatory experience and deliverable format match the exact device and market pathway.
